Document is current
Any future updates will be listed below
-
Authors
Suresh, Abhilash
Morton, Sarah U.
Quiat, Daniel
DePalma, Steven R. https://orcid.org/0000-0002-0381-5016
Gorham, Joshua M.
Brueckner, Martina
Tristani-Firouzi, Martin
Gelb, Bruce D.
Seidman, Jonathan G.
Seidman, Christine E.
,
-
Funding
Funding for this research was provided by:
National Institutes of Health (K08HL157653, UM1HL098162, UM1HL128711, UM1HL098123, UM1HL098166, UM1HL098147)
American Heart Association
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 15 July 2025
First Online: 25 July 2025
Declarations
:
: Participants were consented to the CHD GENES study (Congenital Heart Disease Gene Network Study of the PCGC, clinicaltrials.gov identifier: NCT01196182). All participants or their parents provided written informed consent prior to participation, or legal guardians in the case of participants without capacity to consent. Regulatory oversight and approval were provided via a central Institutional Review Board protocol at the Cincinnati Children’s Hospital Medical Center, with local agreements at each recruitment site. Non-CHD participants comprised sibling–parent trios, unaffected by CHD or autism, derived from the Simons Foundation sporadic autism quartets that consisted of one offspring with autism, one unaffected sibling and their unaffected parents []. This study adhered to the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
